Kerecis Limited
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$14Mgeneral payments (2019-2025)
$799Kresearch payments (2019-2025)
23,306clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Robert Kirsner | Miami, FL | Dermatology | $1,115,946.36 |
| Michael Lacqua | Brooklyn, NY | Plastic Surgery | $807,983.28 |
| John Lantis | New York, NY | Vascular Surgery | $359,232.63 |
| Alfredo Cordova | Sarasota, FL | Surgical Critical Care | $270,739.12 |
| Marcus Duda | Greensboro, NC | Orthopaedic Surgery | $249,769.97 |
| Mark Suski | Thousand Oaks, CA | Plastic and Reconstructive Surgery | $239,563.26 |
| Rajiv Sood | Augusta, GA | Plastic and Reconstructive Surgery | $216,607.65 |
| Karl Stark | North Kansas City, MO | Vascular Surgery | $203,998.86 |
| Patrick Mceneaney | Cary, IL | Foot & Ankle Surgery | $190,714.87 |
| Sai Ramakrishna Velamuri Venkata | Tampa, FL | Plastic and Reconstructive Surgery | $168,532.26 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.